Encompass Health Net Income/Loss 2010-2025 | EHC

Encompass Health annual/quarterly net income/loss history and growth rate from 2010 to 2025. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
  • Encompass Health net income/loss for the quarter ending March 31, 2025 was $0.597B, a 28.86% increase year-over-year.
  • Encompass Health net income/loss for the twelve months ending March 31, 2025 was $1.453B, a 26.28% increase year-over-year.
  • Encompass Health annual net income/loss for 2024 was $0.597B, a 28.86% increase from 2023.
  • Encompass Health annual net income/loss for 2023 was $0.463B, a 26.54% increase from 2022.
  • Encompass Health annual net income/loss for 2022 was $0.366B, a 29.25% decline from 2021.
Encompass Health Annual Net Income/Loss
(Millions of US $)
2024 $597
2023 $463
2022 $366
2021 $517
2020 $369
2019 $446
2018 $375
2017 $350
2016 $318
2015 $253
2014 $282
2013 $381
2012 $236
2011 $255
2010 $940
2009 $129
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.183B $5.373B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.868B 19.58
DaVita (DVA) United States $10.978B 15.44
Chemed (CHE) United States $8.483B 26.66
Elanco Animal Health (ELAN) United States $6.417B 13.74
Option Care Health (OPCH) United States $5.441B 24.26
RadNet (RDNT) United States $4.587B 291.14
Amedisys (AMED) United States $3.105B 20.89
LifeStance Health (LFST) United States $2.271B 0.00
Addus HomeCare (ADUS) United States $2.054B 22.55
Astrana Health (ASTH) United States $1.524B 37.75
U.S Physical Therapy (USPH) United States $1.213B 31.31
Aveanna Healthcare Holdings (AVAH) United States $1.169B 66.56
Pennant (PNTG) United States $1.042B 38.25
Atai Life Sciences (ATAI) Germany $0.331B 0.00
Daxor (DXR) United States $0.037B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00